The company will use the new funds to expand Health Catalyst’s technology and services offerings, including the Health Catalyst Data Operating System, a data warehouse and application development platform. It will also support the company’s “expansion, already underway, into the life sciences and international markets,” said Health Catalyst CEO Dan Burton.
OrbiMed, a healthcare public and private market investment firm, led the equity and debt funding round. Other investors were Sequoia Capital, UPMC Enterprises and Kaiser Permanente Ventures.
More articles on health IT:
Epic named ‘Best in KLAS’ overall software suite for 9th straight year
How ‘big tech’ fared last quarter: Earnings from Amazon, Google, Apple & more
Former ONC chief Dr. Karen DeSalvo to advise digital health investment firm: 4 notes
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
